This webinar was held on Wednesday, September 14, 2022.
It’s estimated that more than 80% of those properly diagnosed with idopathic Normal Pressure Hydrocephalus (iNPH) and screened for shunt responsiveness will experience rapid improvement in their condition. Physicians, medical device manufacturers, and patient advocates are cooperating on a variety of levels to improve methods of diagnosis, techniques and devices for treatment.
Dr. Hamilton, Director of the Adult Hydrocephalus Program at the University of Calgary, and Dr. Lee, Director of Cerebrospinal Fluid Surgery Program at USC have a conversation around the similarities & differences in approach to iNPH Diagnosis and Treatment.
Негізгі бет The Journey with iNPH: From Diagnosis to Treatment
Пікірлер